WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123768) PEPTIDE-BASED COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123768    International Application No.:    PCT/NO2005/000210
Publication Date: 29.12.2005 International Filing Date: 15.06.2005
IPC:
C07K 14/705 (2006.01), C07K 5/09 (2006.01), G01N 33/68 (2006.01), A61K 38/17 (2006.01)
Applicants: GE HEALTHCARE AS [NO/NO]; Intellectual Property Dept., P.O. Box 4220 Nydalen, Nycoveien 1-2, N-0401 Oslo (NO) (For All Designated States Except US).
CUTHBERTSON, Alan [GB/NO]; (NO) (For US Only).
NAIRNE, Robert, James [GB/GB]; (GB) (For US Only)
Inventors: CUTHBERTSON, Alan; (NO).
NAIRNE, Robert, James; (GB)
Agent: WULFF, Marianne, Weiby; GE HEALTHCARE AS, P.O. Box 4220 Nydalen, Nycoveien 1-2, N-0401 Oslo (NO)
Priority Data:
20042523 16.06.2004 NO
Title (EN) PEPTIDE-BASED COMPOUNDS
(FR) COMPOSÉS À BASE DE PEPTIDES
Abstract: front page image
(EN)The invention relates to new peptide-based compounds and their use in diagnostic optical imaging techniques. More specifically the invention relates to the use of such peptide-based compounds as targeting vectors that bind to receptors associated with angiogenesis. The compounds are labelled with at least one cyanine dye reporter and may be used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases.
(FR)L’invention concerne de nouveaux composés à base de peptides et leur utilisation dans les techniques d’imagerie optique de diagnostic. Plus particulièrement, l’invention concerne l’utilisation de ces composés à base de peptides en tant que vecteurs ciblés qui se lient aux récepteurs associés à l’angiogenèse. Les composés sont marqués avec au moins un indicateur constitué d’un colorant de cyanine et peuvent être utilisés en tant qu’agents de contraste en imagerie optique dans le diagnostic des maladies relatives à l’angiogenèse.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)